Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Theranyx Sarl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11272
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theranyx Sarl is a bio technology company that develops novel therapeutic drugs and solutions to treat cancer. The company’s main line business involved in generation of functional antibodies to target GPCRs and ion channel receptors. Its antibodies named as Therabodies has scope in target validation, diagnostics, therapeutic use and antibody drug conjugate (ADC). The company collaborated with biotechnology and pharmaceutical companies for developing novel targets to identify cancer indications. It developed a robust platform to develop purified, stabilized and functional membrane proteins that are used for the development of novel therapeutic molecules. Theranyx is headquartered in Marseille, Cedex , France.

Theranyx Sarl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theranyx Sarl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Theranyx Sarl, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tetragenetics Enters into Agreement with Theranyx 10
LegoChem Biosciences Enters into Agreement with Theranyx 11
Debt Offering 12
Theranyx Raises USD0.4 Million in Private Placement of Bonds 12
Theranyx Sarl – Key Competitors 13
Theranyx Sarl – Key Employees 14
Theranyx Sarl – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Theranyx Sarl, Pharmaceuticals & Healthcare, Key Facts 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theranyx Sarl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theranyx Sarl, Deals By Therapy Area, 2012 to YTD 2018 8
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tetragenetics Enters into Agreement with Theranyx 10
LegoChem Biosciences Enters into Agreement with Theranyx 11
Theranyx Raises USD0.4 Million in Private Placement of Bonds 12
Theranyx Sarl, Key Competitors 13
Theranyx Sarl, Key Employees 14

List of Figures
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biosceptre International Ltd-医療機器分野:企業M&A・提携分析
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Biosceptre’s diagnostic products are …
  • China Eastern Airlines Corporation Limited
    China Eastern Airlines Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Eastern Airlines Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • KYORIN Holdings Inc (4569):製薬・医療:M&Aディール及び事業提携情報
    Summary KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries …
  • Fairfax Financial Holdings Limited:企業の戦略・SWOT・財務情報
    Fairfax Financial Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Financial Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • CG Power and Industrial Solutions Ltd (CGPOWER):企業の財務・戦略的SWOT分析
    CG Power and Industrial Solutions Ltd (CGPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Abiomed Inc (ABMD)-医療機器分野:企業M&A・提携分析
    Summary Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for cir …
  • POET Technologies Inc (PTK):電力:M&Aディール及び事業提携情報
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company provides products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among …
  • Diamondback Energy Inc (FANG):石油・ガス:M&Aディール及び事業提携情報
    Summary Diamondback Energy Inc (Diamondback Energy) is an oil and gas company that offers exploration and development programs. The company acquires, develops, explores and exploits unconventional, onshore oil and natural gas reserves in Permian Basin in West Texas. It develops the reserves and prod …
  • S-Oil Corporation Inc (010950)-石油・ガス分野:企業M&A・提携分析
    Summary S-Oil Corporation Inc (S-Oil) is a service driven company that operates in the petroleum and petrochemical industry. The company imports and exports crude oil; as well as manufactures and sells oil refining products, petrochemical products and lube products. S-Oil also produces a wide range …
  • Netflix, Inc.:企業の戦略・SWOT・財務情報
    Netflix, Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • C-TRI Co Ltd (047920):製薬・医療:M&Aディール及び事業提携情報
    Summary C-TRI Co Ltd (C-TRI), a subsidiary of DAE HWA Pharmaceutical Co Ltd, is a pharmaceutical company that offers development of new peptide drugs. The company’s products include ethicals, over-the-counter drugs, Quasi-drugs, cosmetics, amendments, pharmaceuticals, taltirelin, desmopressin, presc …
  • Hoosier Energy Rural Electric Cooperative, Inc.:発電所・企業SWOT分析
    Hoosier Energy Rural Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, …
  • Suzuken Co., Ltd.:企業の戦略・SWOT・財務情報
    Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sekisui Diagnostics LLC:製品パイプライン分析
    Summary Sekisui Diagnostics LLC (Sekisui Diagnostics), a subsidiary of Sekisui Chemical Co Ltd is a medical device company that develops, manufactures and supplies clinical diagnostic and research products. The company’s products include coagulation, clinical chemistry, virotech products, OSOM rapid …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CLAAS KGaA mbH:企業の戦略的SWOT分析
    CLAAS KGaA mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Commonwealth Bank of Australia:企業のM&A・事業提携・投資動向
    Commonwealth Bank of Australia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Commonwealth Bank of Australia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Compagnie Ivoirienne d’Electricite (CIEC):企業の財務・戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove, is a power company that provides power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It provides operation and management of hydroelectric and therm …
  • CIBC Wealth Management:企業の戦略・SWOT・財務分析
    CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆